Abstract:Cerebral small vessel disease (SVD) causes lacunar stroke and intracerebral hemorrhage, and is the most common pathology underlying vascular cognitive impairment. Increasingly, the importance of other clinical features of SVD is being recognized including motor impairment, (vascular) parkinsonism, impaired balance, falls, and behavioral symptoms, such as depression, apathy, and personality change. Epidemiological data show a high prevalence of the characteristic magnetic resonance imaging (MRI) features of white matter hyperintensities and lacunar infarcts in community studies, and recent data suggest that it is also a major health burden in low- and middle-income countries. In this review, we cover advances in diagnosis, imaging, clinical presentations, pathogenesis, and treatment.The two most common pathologies underlying SVD are arteriolosclerosis caused by aging, hypertension, and other conventional vascular risk factors, and cerebral amyloid angiopathy (CAA) caused by vascular deposition of β-amyloid. We discuss the revised Boston criteria of CAA based on MRI features, which have been recently validated. Imaging is providing important insights into pathogenesis, including improved detection of tissue damage using diffusion tensor imaging (DTI) leading to its use to monitor progression and surrogate endpoints in clinical trials. Advanced MRI techniques can demonstrate functional or dynamic abnormalities of the blood vessels, while the high spatial resolution provided by ultrahigh field MRI at 7 T allows imaging of individual perforating arteries for the first time, and the measurement of flow velocity and pulsatility within these arteries. DTI and structural network analysis have highlighted the importance of network disruption in mediating the effect of different SVD pathologies in causing a number of symptoms, including cognitive impairment, apathy, and gait disturbance.Despite the public health importance of SVD, there are few proven treatments. We review the evidence for primary prevention, and recent data showing how intensive blood pressure lowering reduces white matter hyperintensities (WMH) progression and delays the onset of cognitive impairment. There are few treatments for secondary prevention, but a number of trials are currently evaluating novel treatment approaches. Recent advances have implicated molecular processes related to endothelial dysfunction, nitric oxide synthesis, blood-brain barrier integrity, maintenance and repair of the extracellular matrix, and inflammation. Novel treatment approaches are being developed to a number of these targets. Finally, we highlight the importance of large International collaborative initiatives in SVD to address important research questions and cover a number which have recently been established.

Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease

Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease

Quantity and Morphology of Perivascular Spaces: Associations with Vascular Risk Factors and Cerebral Small Vessel Disease

The Relationship Between Deep Medullary Veins Score and the Severity and Distribution of Intracranial Microbleeds

The relationship between blood-brain barrier permeability and enlarged perivascular spaces: a cross-sectional study.

MRI-visible perivascular spaces in basal ganglia but not centrum semiovale or hippocampus were related to deep medullary veins changes

Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain

Cerebral small vessel disease: Recent advances and future directions

Heterogeneous blood‐brain barrier dysfunction in cerebral small vessel diseases

Decreased Cerebral Blood Flow and Delayed Arterial Transit Are Independently Associated With White Matter Hyperintensity.

Role of Deep Medullary Veins in Pathogenesis of Lacunes: Longitudinal Observations from the CIRCLE Study

Abstract 118: Cerebral Venous Reflux And Dilated Basal Ganglia Perivascular Space In Hypertensive Small Vessel Disease

Abstract TMP7: Disruption of Blood Brain Barrier is Associated With Silent Cerebral Infarcts in Patients With Sickle Cell Disease

Retinal capillary microvessel morphology changes are associated with vascular damage and dysfunction in cerebral small vessel disease

Pathogenesis of white matter changes in cerebral small vessel diseases: beyond vessel-intrinsic mechanisms

Quantitative comparison of CSVD imaging markers between patients with possible amyloid small vessel disease and with non-amyloid small vessel disease

Blood-brain barrier leakage in the penumbra is associated with infarction on follow-up imaging in acute ischemic stroke

Pathophysiology of cerebral small vessel disease: a journey through recent discoveries

[Cerebral Small Vessel Disease: Advances in Understanding its Pathophysiology]

Risk of Nursing Home Admission in Cerebral Small Vessel Disease

Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study